Industry hits back at Commission probe
December 4, 2008Sales and Marketing Europe, reform
The pharmaceutical industry has hit back at what it says is an ill-informed attack on the sector by the European …
Boehringer to switch Flomax from POM to P
December 3, 2008Sales and Marketing OTC
Boehringer Ingelheim's consumer arm has applied to make its urological disorder drug Flomax (tamsulosin) available in the UK from pharmacists …
Cancer deaths in England down
December 3, 2008Sales and Marketing NHS
Cancer death rates in England have dropped and one-year survival rates are up, according to the Department of Health. But …
MedImmune’s respiratory treatment faces US approval delay
December 3, 2008Sales and Marketing US, reg, resp
One of MedImmune's key products has hit a delay in the US, after regulators demanded further data. The FDA asked …
Not a ‘polyclinic’: Johnson opens the first GP-led health centre
December 3, 2008NHS, reform
The first of a new generation of primary care centres has been opened in Bradford, which the government hopes will …
Effective marketing training
December 3, 2008Business Services careers, training
When the UK's Olympics team came home from Beijing this summer, laden with a record haul of medals, the nation …
Hope for Obama’s healthcare IT plan
December 1, 2008Sales and Marketing US, hc, reform
The election of Barack Obama has brought high expectations, with his "Change Can Happen" mantra signaling to many that a …
Daiichi Sankyo sets up Ireland operations
November 27, 2008Sales and Marketing Daiichi, Ireland
Japanese company Daiichi Sankyo is continuing its expansion in Europe with the launch of operations in Ireland.The new subsidiary's headquarters …
Commission to reveal anti-competitive probe findings
November 27, 2008Sales and Marketing EU, reg
The European pharmaceutical industry could shortly face a major inquiry into its practices, with the European Commission ready to reveal …
Grunenthal’s new pain treatment approved in US
November 27, 2008Sales and Marketing Grunenthal
The first new oral centrally acting analgesic in more than 25 years has been approved in the US.Tapentadol was developed …
BMS breast cancer drug rejected
November 27, 2008Sales and Marketing BMS, Cancer, breast cancer
Bristol-Myers Squibb's breast cancer drug Ixempra has suffered a setback in the EU over safety concerns.The Committee for Medicinal Products …
Government hopes World Class Commissioning can save money
November 27, 2008Sales and Marketing NHS, primary
The government is looking to the NHS to produce huge new savings as part of its rescue package for the …
Roche’s RoActemra recommended for approval
November 26, 2008Sales and Marketing RA, Roche
European regulators have recommended Roche's RoActemra be approved to treat moderate to severe rheumatoid arthritis. The novel drug, known as …
Frontline staff to have their say on NHS quality indicators
November 25, 2008NHS, hc
Doctors and nurses are to decide on a series of quality indicators that will measure how well the NHS is …
Latest news from Datamonitor
November 24, 2008Sales and Marketing digi, hc
Personal health records will play an important role in the exchange of health informationEarly successes in healthcare interoperability are paving …
Flexible pricing PPRS hailed as a ‘landmark’ deal
November 21, 2008Sales and Marketing ABPI, par
The future of UK medicines could be revolutionised by a new deal that contains two pioneering measures on flexible prices …
AZ to cut 1,400 manufacturing and supply chain jobs
November 21, 2008Manufacturing and Production AZ
AstraZeneca has announced the loss of 1,400 jobs in its European manufacturing and supply chain infrastructure.The company says the introduction …
Over-the-counter Viagra bid ends
November 21, 2008Sales and Marketing ED, OTC, viagra
Plans to make Viagra available through pharmacies in Europe without a prescription have been scuppered by safety concerns.Pfizer has ended …
Boehringer’s cancer drug enters phase III
November 21, 2008Sales and Marketing Boehringer, Cancer
Boehringer Ingelheim's new lung cancer drug Vargatef has entered phase III trials.The drug is part of the manufacturer's burgeoning oncology …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
